Total Visits

Views
DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer38

Select a period of time:

Views

Views
January 20250
February 20252
March 202517
April 20252
May 20251
June 20253
July 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore17
United States4
Brazil2
Spain1
Hong Kong1
 

Top cities views

Views
Bebedouro1
Council Bluffs1
Hong Kong1
New York1
Olinda1